Reactivation of HIC‑1 gene by saRNA inhibits clonogenicity and invasiveness in breast cancer cells

Zhao,Feng; Pan,Shengli; Gu,Yan; Guo,Shanyu; Dai,Qiancheng; Yu,Yingyan; Zhang,Wei

doi:10.3892/ol.2014.2633

Reactivation of HIC‑1 gene by saRNA inhibits clonogenicity and invasiveness in breast cancer cells

Authors:
- Feng Zhao
- Shengli Pan
- Yan Gu
- Shanyu Guo
- Qiancheng Dai
- Yingyan Yu
- Wei Zhang
View Affiliations

Affiliations: Department of Surgery, The Ninth People's Hospital of Shanghai Jiao Tong University, School of Medicine, Shanghai 200011, P.R. China, Department of Surgery, Shanghai Ruijin Hospital of Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, P.R. China
Published online on: October 24, 2014 https://doi.org/10.3892/ol.2014.2633
Pages: 159-164

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hypermethylated in cancer 1 (HIC‑1) is a tumor suppressor gene, which is epigenetically silenced in breast cancer. It is known that the loss of HIC‑1, caused by promoter hypermethylation, is associated with tumor aggression and poor survival in breast carcinoma. It has been shown that small activating RNA (saRNA) targeting promoter sequences may induce gene re‑expression. In the current study, saRNA was used to restore HIC‑1 expression, and the effects on colony formation, invasiveness and the cell cycle in breast cancer cells were explored. dsHIC1‑2998, an saRNA, exhibited activating efficacy on MCF‑7 and MDA‑MB‑231 cancer cell lines. A clonogenicity assay showed that evident colony inhibition was induced via saRNA‑mediated re‑expression of HIC‑1 in the two cancer cell lines. Reactivation of HIC‑1 significantly inhibited cell migration and invasion, resulting in G0/G1 cell cycle arrest in these cell lines. These findings suggest that HIC‑1 may be a potential target in gene therapy for the treatment of breast cancer. saRNA may function as a therapeutic option for upregulating tumor suppressor genes in breast cancer.

View Figures

View References

1	Deltour S, Guerardel C, Stehelin D and Leprince D: The carboxy-terminal end of the candidate tumor suppressor gene HIC-1 is phylogenetically conserved. Biochim Biophys Acta. 1443:230–232. 1998. View Article : Google Scholar : PubMed/NCBI
2	Hayashi M, Tokuchi Y, Hashimoto T, et al: Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance. Anticancer Res. 21:535–540. 2001.PubMed/NCBI
3	Kanai Y, Hui AM, Sun L, et al: DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are associated with hepatocarcinogenesis. Hepatology. 29:703–709. 1999. View Article : Google Scholar : PubMed/NCBI
4	Pan S, Wang Z, Chen Y, et al: Inactivation of tumor suppressor gene HIC1 in gastric cancer is reversed via small activating RNAs. Gene. 527:102–108. 2013. View Article : Google Scholar : PubMed/NCBI
5	Rood BR, Zhang H, Weitman DM and Cogen PH: Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma. Cancer Res. 62:3794–3797. 2002.PubMed/NCBI
6	Fujii H, Biel MA, Zhou W, Weitzman SA, Baylin SB and Gabrielson E: Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer. Oncogene. 16:2159–2164. 1998. View Article : Google Scholar : PubMed/NCBI
7	Boulay G, Malaquin N, Loison I, et al: Loss of Hypermethylated in Cancer 1 (HIC1) in breast cancer cells contributes to stress-induced migration and invasion through β-2 adrenergic receptor (ADRB2) misregulation. J Biol Chem. 287:5379–5389. 2012. View Article : Google Scholar :
8	Brieger J, Pongsapich W, Mann SA, et al: Demethylation treatment restores hic1 expression and impairs aggressiveness of head and neck squamous cell carcinoma. Oral Oncol. 46:678–683. 2010. View Article : Google Scholar : PubMed/NCBI
9	Li LC, Okino ST, Zhao H, et al: Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci USA. 103:17337–17342. 2006. View Article : Google Scholar : PubMed/NCBI
10	Janowski BA, Younger ST, Hardy DB, Ram R, Huffman KE and Corey DR: Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat Chem Biol. 3:166–173. 2007. View Article : Google Scholar : PubMed/NCBI
11	Chen Z, Place RF, Jia ZJ, Pookot D, Dahiya R and Li LC: Antitumor effect of dsRNA-induced p21(WAF1/CIP1) gene activation in human bladder cancer cells. Mol Cancer Ther. 7:698–703. 2008. View Article : Google Scholar : PubMed/NCBI
12	Yang K, Zheng XY, Qin J, et al: Up-regulation of p21WAF1/Cip1 by saRNA induces G1-phase arrest and apoptosis in T24 human bladder cancer cells. Cancer Lett. 265:206–214. 2008. View Article : Google Scholar : PubMed/NCBI
13	Ren S, Kang MR, Wang J, et al: Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth. Prostat. 72:1591–1601. 2013. View Article : Google Scholar
14	Zhao F, Pan S, Gu Y, et al: Small activating RNA restores the activity of the tumor suppressor HIC-1 on breast cancer. PLoS One. 9:e864862014. View Article : Google Scholar : PubMed/NCBI
15	Huang V, Qin Y, Wang J, et al: RNAa is conserved in mammalian cells. PLoS One. 5:e88482010. View Article : Google Scholar : PubMed/NCBI
16	Portnoy V, Huang V, Place RF and Li LC: Small RNA and transcriptional upregulation. Wiley Interdiscip Rev RNA. 2:748–760. 2011. View Article : Google Scholar : PubMed/NCBI
17	Hu J, Chen Z, Xia D, Wu J, Xu H and Ye ZQ: Promoter-associated small double-stranded RNA interacts with heterogeneous nuclear ribonucleoprotein A2/B1 to induce transcriptional activation. Biochem J. 447:407–416. 2012. View Article : Google Scholar : PubMed/NCBI
18	Kosaka M, Kang MR, Yang G and Li LC: Targeted p21(WAF1/CIP1) activation by RNAa inhibits hepatocellular carcinoma cells. Nucleic Acid Ther. 22:335–343. 2012.PubMed/NCBI
19	Qin Q, Lin YW, Zheng XY, et al: RNAa-mediated overexpression of WT1 induces apoptosis in HepG2 cells. World J Surg Oncol. 10:112012. View Article : Google Scholar : PubMed/NCBI
20	Chen R, Wang T, Rao K, et al: Up-regulation of VEGF by small activator RNA in human corpus cavernosum smooth muscle cells. J Sex Med. 8:2773–2780. 2011. View Article : Google Scholar : PubMed/NCBI
21	Junxia W, Ping G, Yuan H, et al: Double strand RNA-guided endogeneous E-cadherin up-regulation induces the apoptosis and inhibits proliferation of breast carcinoma cells in vitro and in vivo. Cancer Sci. 101:1790–1796. 2010. View Article : Google Scholar : PubMed/NCBI
22	Mao Q, Li Y, Zheng X, et al: Up-regulation of E-cadherin by small activating RNA inhibits cell invasion and migration in 5637 human bladder cancer cells. Biochem Biophys Res Commun. 375:566–570. 2008. View Article : Google Scholar : PubMed/NCBI
23	Wei J, Zhao J, Long M, et al: p21WAF1/CIP1 gene transcriptional activation exerts cell growth inhibition and enhances chemosensitivity to cisplatin in lung carcinoma cell. BMC Cancer. 10:6322010. View Article : Google Scholar : PubMed/NCBI
24	Wu ZM, Dai C, Huang Y, et al: Anti-cancer effects of p21WAF1/CIP1 transcriptional activation induced by dsRNAs in human hepatocellular carcinoma cell lines. Acta Pharmacol Sin. 32:939–946. 2011. View Article : Google Scholar : PubMed/NCBI
25	Kang MR, Yang G, Place RF, et al: Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth. Cancer Res. 72:5069–5079. 2012. View Article : Google Scholar : PubMed/NCBI
26	Dehennaut V, Loison I, Dubuissez M, Nassour J, Abbadie C and Leprince D: DNA double-strand breaks lead to activation of hypermethylated in cancer 1 (HIC1) by SUMOylation to regulate DNA repair. J Biol Chem. 288:10254–10264. 2013. View Article : Google Scholar : PubMed/NCBI
27	Cheng G, Sun X, Wang J, et al: HIC1 silencing in triple-negative breast cancer drives progression through misregulation of LCN2. Cancer Res. 74:862–872. 2014. View Article : Google Scholar
28	Parrella P, Scintu M, Prencipe M, et al: HIC1 promoter methylation and 17p13.3 allelic loss in invasive ductal carcinoma of the breast. Cancer Lett. 222:75–81. 2005. View Article : Google Scholar : PubMed/NCBI